Reuters: Investor values Nobel Biocare 30 to 50 percent higher: Barrons

[chris]

Investor values Nobel Biocare 30 to 50 percent higher: Barrons
      

NEW YORK (Reuters) - Nobel Biocare Holding AG  may be worth 30 percent to 50 percent more than its current share price according to a Barron's April 7 story, citing a investor's estimated value for the company.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login